Aerie Pharmaceuticals (AERI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
15.25 +0.01 (+0.07%) 11/18/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 15.25 unch (unch) -
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 27,185 | 22,970 | 24,683 | 20,081 | 18,033 |
| Cost of Goods | 6,177 | 6,700 | 6,534 | 5,381 | 7,326 |
| Gross Profit | 21,008 | 16,270 | 18,149 | 14,700 | 10,707 |
| Operating Expenses | 52,686 | 51,189 | 54,276 | 48,685 | 53,586 |
| Operating Income | -31,501 | -34,219 | -35,593 | -33,604 | -42,553 |
| Other Income | -7,169 | -7,714 | -5,266 | -6,044 | -5,634 |
| Pre-tax Income | -38,670 | -41,933 | -40,859 | -39,648 | -48,187 |
| Income Tax | 18 | 31 | 5,278 | N/A | N/A |
| Net Income Continuous | -38,688 | -41,964 | -46,137 | -39,648 | -48,187 |
| Net Income | $-38,688 | $-41,964 | $-46,137 | $-39,648 | $-48,187 |
| EPS Basic Total Ops | -0.84 | -0.91 | -1.01 | -0.86 | -1.05 |
| EPS Basic Continuous Ops | -0.84 | -0.91 | -1.00 | -0.86 | -1.05 |
| EPS Diluted Total Ops | -0.84 | -0.91 | -1.01 | -0.86 | -1.05 |
| EPS Diluted Continuous Ops | -0.84 | -0.91 | -1.00 | -0.86 | -1.05 |
| EPS Diluted Before Non-Recurring Items | -0.67 | -0.72 | -0.79 | N/A | N/A |
| EBITDA(a) | $-22,299 | $-25,312 | $-26,622 | $-24,961 | $-34,185 |